Xingqi eye drops: Lidocaine hydrochloride eye gel officially enters phase III clinical trials.

Xingqi Eye Medicine announced that the company's developed Lidocaine Hydrochloride Eye Gel for the Evaluation of the Effectiveness and Safety of Lidocaine Hydrochloride Eye Gel for Ocular Surface Anesthesia was the first trial subject to enter the randomized, double-blind, positive drug parallel control, placebo parallel control, multicenter clinical trial, officially entering Phase III clinical trials today.